Zum Hauptinhalt springen Zur Suche springen Zur Hauptnavigation springen
Dekorationsartikel gehören nicht zum Leistungsumfang.
Real-World Evidence in Drug Development and Evaluation
Taschenbuch von Harry Yang (u. a.)
Sprache: Englisch

56,30 €*

inkl. MwSt.

Versandkostenfrei per Post / DHL

Lieferzeit 4-7 Werktage

Produkt Anzahl: Gib den gewünschten Wert ein oder benutze die Schaltflächen um die Anzahl zu erhöhen oder zu reduzieren.
Kategorien:
Beschreibung

Real-world evidence (RWE) has been at the forefront of pharmaceutical innovations. It plays an important role in transforming drug development from a process aimed at meeting regulatory expectations to an operating model that leverages data from disparate sources to aid business, regulatory, and healthcare decision making. Despite its many benefits, there is no single book systematically covering the latest development in the field.

Written specifically for pharmaceutical practitioners, Real-World Evidence in Drug Development and Evaluation, presents a wide range of RWE applications throughout the lifecycle of drug product development. With contributions from experienced researchers in the pharmaceutical industry, the book discusses at length RWE opportunities, challenges, and solutions.

Features

  • Provides the first book and a single source of information on RWE in drug development
  • Covers a broad array of topics on outcomes- and value-based RWE assessments
  • Demonstrates proper Bayesian application and causal inference for real-world data (RWD)
  • Presents real-world use cases to illustrate the use of advanced analytics and statistical methods to generate insights
  • Offers a balanced discussion of practical RWE issues at hand and technical solutions suitable for practitioners with limited data science expertise

Real-world evidence (RWE) has been at the forefront of pharmaceutical innovations. It plays an important role in transforming drug development from a process aimed at meeting regulatory expectations to an operating model that leverages data from disparate sources to aid business, regulatory, and healthcare decision making. Despite its many benefits, there is no single book systematically covering the latest development in the field.

Written specifically for pharmaceutical practitioners, Real-World Evidence in Drug Development and Evaluation, presents a wide range of RWE applications throughout the lifecycle of drug product development. With contributions from experienced researchers in the pharmaceutical industry, the book discusses at length RWE opportunities, challenges, and solutions.

Features

  • Provides the first book and a single source of information on RWE in drug development
  • Covers a broad array of topics on outcomes- and value-based RWE assessments
  • Demonstrates proper Bayesian application and causal inference for real-world data (RWD)
  • Presents real-world use cases to illustrate the use of advanced analytics and statistical methods to generate insights
  • Offers a balanced discussion of practical RWE issues at hand and technical solutions suitable for practitioners with limited data science expertise
Inhaltsverzeichnis
1 Using Real-world Evidence to Transform Drug Development: Opportunities and Challenges. 2. Evidence derived from real world data: utility, constraints and cautions. 3. Real-World Evidence from Population-Based Cancer Registry Data. 4. External Control using RWE and Historical Data in Clinical Development. 5. Bayesian method for assessing drug safety using real-world evidence. 6. Real-World Evidence for Coverage and Payment Decisions. 7. Causal Inference for Observational Studies/Real-World Data. 8. Introduction to Artificial Intelligence and Deep Learning with a Case Study in Analyzing Electronic Health Records for Drug Development.
Details
Medium: Taschenbuch
ISBN-13: 9780367637019
ISBN-10: 0367637014
Sprache: Englisch
Redaktion: Yang, Harry
Yu, Binbing
Hersteller: Taylor & Francis
Chapman and Hall/CRC
Verantwortliche Person für die EU: preigu, Ansas Meyer, Lengericher Landstr. 19, D-49078 Osnabrück, mail@preigu.de
Abbildungen: 30 SW-Abb., 20 Tabellen
Maße: 10 x 156 x 234 mm
Von/Mit: Harry Yang (u. a.)
Erscheinungsdatum: 29.08.2022
Gewicht: 0,285 kg
Artikel-ID: 125177771
Inhaltsverzeichnis
1 Using Real-world Evidence to Transform Drug Development: Opportunities and Challenges. 2. Evidence derived from real world data: utility, constraints and cautions. 3. Real-World Evidence from Population-Based Cancer Registry Data. 4. External Control using RWE and Historical Data in Clinical Development. 5. Bayesian method for assessing drug safety using real-world evidence. 6. Real-World Evidence for Coverage and Payment Decisions. 7. Causal Inference for Observational Studies/Real-World Data. 8. Introduction to Artificial Intelligence and Deep Learning with a Case Study in Analyzing Electronic Health Records for Drug Development.
Details
Medium: Taschenbuch
ISBN-13: 9780367637019
ISBN-10: 0367637014
Sprache: Englisch
Redaktion: Yang, Harry
Yu, Binbing
Hersteller: Taylor & Francis
Chapman and Hall/CRC
Verantwortliche Person für die EU: preigu, Ansas Meyer, Lengericher Landstr. 19, D-49078 Osnabrück, mail@preigu.de
Abbildungen: 30 SW-Abb., 20 Tabellen
Maße: 10 x 156 x 234 mm
Von/Mit: Harry Yang (u. a.)
Erscheinungsdatum: 29.08.2022
Gewicht: 0,285 kg
Artikel-ID: 125177771
Sicherheitshinweis

Ähnliche Produkte

Ähnliche Produkte